Sarah Fitzgerald, a graduate student in the Experimental Therapeutics and Pharmacology program, will defend her dissertation, "The Role of Th17 cells versus IL-17 Signaling in the Pathophysiology of Preeclampsia," at 2:30 p.m. on Wednesday, August 23 in the Research Wing – R434. All Medical Center faculty, staff, and students are invited to attend. For more information, please contact Melody Turner.
